As mentioned above, DNMTs are considered promising targets for the epigenetic treatment of tumours; therefore, it is not surprising that DNMT inhibitors have aroused substantial attention in recent years with respect to the regulation of aberrant DNA methylation patterns. Here, DNMT1 is linked to neoplasm.